Navigation Links
NIST, NCI bring web 2.0 tools to nanotechnology standards effort
Date:11/13/2008

Federal government and U.S. industry scientists say they are forging ahead with plans for an international, online collaboration to speed up creation of critically needed nanotechnology standards, including the underpinning reference materials and tests that support development of nanotech products while minimizing potential risks.

Combining efforts of materials scientists and measurement laboratories with those of biological and medical researchers, the new Internet-linked "community of interest" will exploit Web 2.0-style social networking technologies to enable creating and sharing information, as well as deliberating over technical details of in-process standards. The initial focus will be standards for characterizing the structure and properties of engineered nanoscale materials.

The global market for nanotechnology-enabled products is forecast to top $3 trillion by 2015. This anticipated stream of nanotech innovations has spawned a backlog of standards needs.

The idea for the Web-based collaboration was strongly endorsed during a recent international workshop hosted by the National Institute of Standards and Technology (NIST). A prototype wikior collaborative Web sitewas demonstrated by representatives of the National Cancer Institute's (NCI's) Advanced Biomedical Computing Center.

Now undergoing further development at NCI, the nanotechnology standards wiki will enable instantaneous dissemination (as well as archival) of drafts, discussions, votes and supporting materials. Wiki-related tools will help in organizing discussions, and standards developing organizations (SDOs) will be able to tap this resource to expedite drafting and validating protocols before they enter the formal approval process.

SDOs are developing standards in the fast-moving technology area, but scientists at the workshop said the overall response is not as effective or as coherent as the global challenge requires.

NCI and its part
'/>"/>

Contact: Mark Bello
mark.bello@nist.gov
301-975-3776
National Institute of Standards and Technology (NIST)
Source:Eurekalert

1

GOOD

Page: 1 2

Related biology news :

1. NIST, Army researchers pave the way for anthrax spore standards
2. Innovations in Pediatric Medicine International Conference brings together pediatrics experts
3. Innovations in Pediatric Medicine CME conference brings together national pediatrics experts
4. Closing the gap: Journal launch brings together wound-healing knowledge
5. World Food Day brings attention to food security around the globe
6. New book brings upper US Gulf Coast climate change and sea-level rise into focus
7. Cryopreservation techniques bring hopes for women cancer victims and endangered species
8. Dirty air brings rain -- then again, maybe not
9. Bringing Martian samples to Earth -- preparations outlined in journal Astrobiology
10. Hot peppers really do bring the heat
11. New ORNL process brings nanoparticles into focus

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...of General Medical Sciences (NIGMS), part of the N...42.3 million for grants in scientific areas it ide...ed the GO grant program to stimulate biomedical re... American Recovery and Reinvestment Act (Recovery ...e to have a significant impact on a field of biome...
(Date:11/23/2009)...aled how environmental irritants such as air pollu... research published today in the American Journal...uthors of the study, from Imperial College London ...action inside the lungs that can trigger coughing ...n the air. They suggest that their findings may ul...
(Date:11/23/2009)...asty business, posing dangers to human health and ...s launching a new project with funding from the U....ets the fat and grease that contribute to millions...ners new tools to further reduce the risk of sewag...y" sewer systems, as opposed to "combined" systems...
Breaking Biology News(10 mins):NIGMS invests in scientific Grand Opportunities with Recovery Act funds 2NIGMS invests in scientific Grand Opportunities with Recovery Act funds 3Research reveals exactly how coughing is triggered by environmental irritants 2Lose the fat: Targeting grease to curtail sewer overflows 2Lilly Receives Fourth FDA Approval for ALIMTA 28R 29 28pemetrexed for injection 29 50746 1Lilly Receives Fourth FDA Approval for ALIMTA 28R 29 28pemetrexed for injection 29 50746 2Lilly Receives Fourth FDA Approval for ALIMTA 28R 29 28pemetrexed for injection 29 50746 3Lilly Receives Fourth FDA Approval for ALIMTA 28R 29 28pemetrexed for injection 29 50746 4Lilly Receives Fourth FDA Approval for ALIMTA 28R 29 28pemetrexed for injection 29 50746 5Lilly Receives Fourth FDA Approval for ALIMTA 28R 29 28pemetrexed for injection 29 50746 6Lilly Receives Fourth FDA Approval for ALIMTA 28R 29 28pemetrexed for injection 29 50746 7CSC to Kick Off National Blood Drive Campaign July 8 at Global Headquarters in Virginia 50743 1CSC to Kick Off National Blood Drive Campaign July 8 at Global Headquarters in Virginia 50743 2Smart for Life 28TM 29 Introduces HeroFiber 28TM 29 to Its Product Line 50740 1Smart for Life 28TM 29 Introduces HeroFiber 28TM 29 to Its Product Line 50740 2
...n human stem cell research, producing embryonic-li...ly speed up the development of treatments for life... The discovery made during a project undertaken wi...anch and the Synthecon Corporation in the United S...with an ethical and reliable source of human stem ...
...e US could soon be asked to approve a human trial ...brid of the HIV and Ebola viruses. Tests on monkey...s far more efficiently than any other method devel...iller viruses sounds horrifying, the risks should ...to develop an effective form of gene therapy to tr...
...sed on a recently published article in Environment...teria and a newly discovered group of marine worms...h uses sunken marine mammals as its sole source of...tal Microbiology, Dr Shana Goffredi and her collea...ia and the Osedax (bone-devouring) group of marine...
Other Biology News:Researchers propose measures to curb lion attacks in Tanzania 2Can two killers make a cure? 2
(Date:11/19/2009)...FirstCall/ -- Omeros Corporation (Nasdaq: OMER ) ...e third quarter ended September 30, 2009. For the ...rted a net loss of $3.9 million, or $1.34 per shar...2.54 per share, for the same period in 2008. For t...ny reported a net loss of $15.5 million, or $5.29 ...
(Date:11/19/2009)...-FirstCall/ -- NeoStem, Inc. (NYSE Amex: NBS ), a...er to its shareholders, discussing the Company,s a...aceuticals Holdings, Inc. (CHBP), an integrated bi...ublic of China. The merger gives NeoStem a control.... Ltd., CHBP,s primary operating subsidiary and a ...
(Date:11/19/2009)...mber 19 MONITORING FORCE GmbH,anno...Flibanserin in the,indication treatment-relevant l...for orphan drug status designation with the Europe...nesia is a complication of the mainstay,treatment ...me of those,affected, since it may be disabling fo...
(Date:11/19/2009)...ne Synthesis Companies Form International Gene Syn...ces in Risk Reduction ,Five Member Companies Rep...city , (PRWEB) November 1...synthesis companies today announced agreement that...omote biosecurity in the gene synthesis industry. ...
Breaking Biology Technology:Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 4
...eutics,Inc. (Nasdaq: FOLD ), a biopharmaceutical ...red pharmacological chaperones for the treatment o... results from its recently,completed Phase 2 clini...),for Fabry disease. As of November 2007, Amigal i...Genetic Therapies (HGT), a business unit of,Shire ...
...lved; Remaining Issues Pertain to cGMP Com...mpany Expects to Resolve cGMP Issues in the Next S...,Pharmaceuticals, Inc. (Nasdaq: IDEV ) today anno... from the U.S. Food and Drug Administration (FDA) ...uring and controls (CMC) NDA,supplement submitted ...
... Inc. enters into an exclusive, distribution agree...d New Zealand -, LA...Technologies &,Bioressources Inc. ("Neptune") (NAS...it has entered into an exclusive distribution agre...ional") for Australia and New,Zealand. AZPA Intern...
Other Biology Technology:Amicus Therapeutics Announces Positive Results From Phase 2 Clinical Trials of Amigal(TM) for Fabry Disease 2Amicus Therapeutics Announces Positive Results From Phase 2 Clinical Trials of Amigal(TM) for Fabry Disease 3Amicus Therapeutics Announces Positive Results From Phase 2 Clinical Trials of Amigal(TM) for Fabry Disease 4Amicus Therapeutics Announces Positive Results From Phase 2 Clinical Trials of Amigal(TM) for Fabry Disease 5Amicus Therapeutics Announces Positive Results From Phase 2 Clinical Trials of Amigal(TM) for Fabry Disease 6Indevus Receives Non-Approvable Letter From FDA for VALSTAR(TM) 2Indevus Receives Non-Approvable Letter From FDA for VALSTAR(TM) 3Indevus Receives Non-Approvable Letter From FDA for VALSTAR(TM) 4Nationwide product launch of NKO(R) planned for February 2008 in Australia and New Zealand 2Nationwide product launch of NKO(R) planned for February 2008 in Australia and New Zealand 3
...loped the Easy-Titer Human IgM Assay Kit to addres...rform assay for Human IgM that eliminates the need...and-read assay that allows the accurate determinat...oximately 30 minutes. The Pierce Easy-Titer Human ...
...ilizer is an aqueous solution that contains a puri...g chemicals in a saline solution, pH 6.5 7.5, and...ne and 0.02% bromonitrodioxane as a preservative. ...bilizer for biologically active components in solu...
Cleanascite HC 16000 from Biotech Support Group
...e Stabilizer is a bovine protein-free alternative ...ueous solution that contains non-toxic chemicals i... - 7.2, and does not contain a preservative. This...other biomolecules that are absorbed or immobilize...
Biology Products: